Earnings Feed
Start Free
Home/Filings/4/0001179110-17-010390
4//SEC Filing

New York & Company, Inc. 4

Accession 0001179110-17-010390

CIK 0001211351operating
View on SEC.govCompany Profile

Filed

Jul 13, 8:00 PM ET

Accepted

Jul 14, 5:24 PM ET

Size

31.7 KB

Accession

0001179110-17-010390

Insider Transaction Report

Form 4
Period: 2017-06-29
New York & Company, Inc.NWY
SCOTT GREGORY J
President
Transactions
  • Award

    Stock Appreciation Rights

    2017-06-29+45,283→ 45,283 total
    Exercise: $1.36Exp: 2021-02-15→ Common Stock (45,283 underlying)
  • Disposition to Issuer

    Stock Appreciation Rights

    2017-06-29−200,000→ 0 total
    Exercise: $6.17Exp: 2021-02-15→ Common Stock (200,000 underlying)
  • Award

    Stock Appreciation Rights

    2017-06-29+101,754→ 101,754 total
    Exercise: $1.36Exp: 2022-04-16→ Common Stock (101,754 underlying)
  • Award

    Stock Appreciation Rights

    2017-06-29+122,580→ 122,580 total
    Exercise: $1.36Exp: 2025-08-25→ Common Stock (122,580 underlying)
  • Disposition to Issuer

    Stock Appreciation Rights

    2017-06-29−700,000→ 0 total
    Exercise: $3.80Exp: 2020-06-01→ Common Stock (700,000 underlying)
  • Award

    Stock Appreciation Rights

    2017-06-29+294,000→ 294,000 total
    Exercise: $1.36Exp: 2020-06-01→ Common Stock (294,000 underlying)
  • Award

    Stock Appreciation Rights

    2017-06-29+111,864→ 111,864 total
    Exercise: $1.36Exp: 2023-08-26→ Common Stock (111,864 underlying)
  • Disposition to Issuer

    Stock Appreciation Rights

    2017-06-29−100,000→ 0 total
    Exercise: $3.47Exp: 2024-08-25→ Common Stock (100,000 underlying)
  • Award

    Stock Appreciation Rights

    2017-06-29+44,999→ 44,999 total
    Exercise: $1.36Exp: 2024-08-25→ Common Stock (44,999 underlying)
Footnotes (14)
  • [F1]Each Stock Appreciation Right (SAR) represents the right to receive a payment measured by the increase in the fair market value of one share of common stock from the date of grant of the SAR to the date of exercise of the SAR. Upon exercise the SARs will be settled in stock.
  • [F10]Represents Replacement SARs granted pursuant to the Company's Stock Appreciation Right and Option Exchange Program which all vest on June 29, 2018.
  • [F11]Represents SARs cancelled pursuant to the Company's Stock Appreciation Right and Option Exchange Program. The reporting person was previously awarded SARs which were exercisable as follows: 25,000 on August 25, 2015, 25,000 on August 25, 2016 and 50,000 on August 25, 2017.
  • [F12]Represents Replacement SARs granted pursuant to the Company's Stock Appreciation Right and Option Exchange Program which vest as follows: 22,501 on August 25, 2017 and 22,498 on June 29, 2018.
  • [F13]Represents SARs cancelled pursuant to the Company's Stock Appreciation Right and Option Exchange Program. The reporting person was previously awarded SARs which were exercisable as follows: 50,000 on August 25, 2016, 50,000 on August 25, 2017 and 100,000 on August 25, 2018.
  • [F14]Represents Replacement SARs granted pursuant to the Company's Stock Appreciation Right and Option Exchange Program which vest as follows: 30,645 on August 25, 2017, 30,645 on June 29, 2018 and 61,290 on August 25, 2018.
  • [F2]Represents SARs cancelled pursuant to the Company's Stock Appreciation Right and Option Exchange Program as more fully described in the Schedule TO, filed with the Securities and Exchange Commission on June 1, 2017. The reporting person was previously awarded SARs which were exercisable as follows: 137,500 on June 1, 2011, 187,500 on June 1, 2012, 187,500 on June 1, 2013, and 187,500 on June 1, 2014.
  • [F3]In exchange for each cancelled award pursuant to the Company's Stock Appreciation Right and Option Exchange Program, the reporting person received a replacement award for a lesser number of SARs with an equal fair value and an exercise price equal to the closing price of the Company's common stock as reported on the New York Stock Exchange on June 29, 2017.
  • [F4]Represents Replacement SARs granted pursuant to the Company's Stock Appreciation Right and Option Exchange Program which all vest on June 29, 2018.
  • [F5]Represents SARs cancelled pursuant to the Company's Stock Appreciation Right and Option Exchange Program. The reporting person was previously awarded SARs which were exercisable as follows: 50,000 on February 15, 2012, 50,000 on February 15, 2013, 50,000 on February 15, 2014, and 50,000 on February 15, 2015.
  • [F6]Represents Replacement SARs granted pursuant to the Company's Stock Appreciation Right and Option Exchange Program which all vest on June 29, 2018.
  • [F7]Represents SARs cancelled pursuant to the Company's Stock Appreciation Right and Option Exchange Program. The reporting person was previously awarded SARs which were all exercisable on April 16, 2015.
  • [F8]Represents Replacement SARs granted pursuant to the Company's Stock Appreciation Right and Option Exchange Program which all vest on June 29, 2018.
  • [F9]Represents SARs cancelled pursuant to the Company's Stock Appreciation Right and Option Exchange Program. The reporting person was previously awarded SARs which were exercisable as follows: 50,000 on August 25, 2014, 50,000 on August 25, 2015 and 100,000 on August 25, 2016.

Documents

1 file

Issuer

New York & Company, Inc.

CIK 0001211351

→
Entity typeoperating

Related Parties

1
  • filerCIK 0001211351

Filing Metadata

Form type
4
Filed
Jul 13, 8:00 PM ET
Accepted
Jul 14, 5:24 PM ET
Size
31.7 KB
View on SEC.gov